Related Experiment Video
Updated: May 27, 2026
06:43
Robotic Duodenal Sleeve Resection for Gastrointestinal Stromal Tumor with Rare Exon 8 KIT Mutation Following Neoadjuvant Imatinib
Published on: April 3, 2026
Special considerations in pediatric gastrointestinal tumors
Alberto S Pappo1, Katherine Janeway, Michael Laquaglia
1St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. alberto.pappo@stjude.org
Journal of Surgical Oncology
|November 10, 2011
Summary
Pediatric gastrointestinal tumors (GIST) are rare but increasingly recognized in children, with unique features distinct from adult GIST. This review offers diagnostic and therapeutic guidelines for managing these challenging pediatric tumors.
Area of Science:
- Pediatric Oncology
- Gastrointestinal Oncology
- Tumor Biology
Background:
- Pediatric gastrointestinal tumors (GIST) are uncommon in children.
- These tumors exhibit distinct biological and clinical characteristics compared to adult GIST.
- Increasing recognition of pediatric GIST necessitates specialized management approaches.
Purpose of the Study:
- To review the biological and clinical features of pediatric GIST.
- To provide diagnostic guidelines for pediatric GIST.
- To offer therapeutic recommendations for managing pediatric GIST.
Main Methods:
- Literature review of pediatric GIST.
- Analysis of biological characteristics.
- Evaluation of clinical presentations.
- Synthesis of diagnostic criteria.
- Compilation of therapeutic strategies.
Main Results:
- Pediatric GIST present unique histopathological and molecular profiles.
- Diagnostic challenges include differentiating from other pediatric abdominal masses.
- Treatment strategies require adaptation for pediatric patients.
Conclusions:
- Pediatric GIST are a distinct entity requiring tailored diagnostic and therapeutic approaches.
- Further research is needed to optimize management of these rare tumors.
- Multidisciplinary collaboration is crucial for effective pediatric GIST care.
Related Concept Videos
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:15Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...